Plan members who have type 2 diabetes (T2D) will now have access to the Livongo by Teladoc Health diabetes management program.
Grand Rapids, Michigan — Support for type 2 diabetes (T2D) is the focus of a new plan offering from Priority Health, the nationally recognized nonprofit health benefits company. Livongo by Teladoc Health encompasses a web portal and a mobile app, and this plan supplement includes such services as 24/7 monitoring and guidance, one-on-one health coaching, and healthy habit guidance.
Alicia Coronas
“Managing a chronic condition like diabetes can be overwhelming and stressful,” said Alicia Coronas, vice president of product solutions and marketing for Priority Health. “Our personalized approach to care at Priority Health is designed to ensure our members are surrounded by collaborative and compassionate support throughout their health journey.”
Other partnerships for Priority Health, with goals to optimize patient health outcomes, include joining with Arine for medication management and pulseData for plan members who have chronic kidney disease.
Read all about the new diabetes management offerings here.
Without IRA Fix, COA Warns Community Oncology Practices Will Shut Down
June 30th 2025Ted Okon, MBA, of the Community Oncology Alliance discusses how community oncology faces a revenue crisis due to the Inflation Reduction Act's impact on Medicare reimbursement, risking patient access to vital cancer treatments.
Read More
Many Patients Stop GLP-1s Before Reaching Target Dose: Hamlet Gasoyan, PhD
June 19th 2025Discontinuing the weight loss treatment before hitting the recommended maintenance dose contributes to low-value care despite provider follow-up and efforts to manage side effects, says Hamlet Gasoyan, PhD, Cleveland Clinic.
Read More
AMGA Releases Population Health Framework to Improve ASCVD Secondary Prevention
June 18th 2025Proven interventions to improve care, address disparities, and support lipid management are woven throughout AMGA Foundation's new framework to guide population health–based secondary prevention strategies for atherosclerotic cardiovascular disease (ASCVD).
Read More